Clinical Development

Brought to you by:
Wall Street stock exchange finance shares share price Nasdaq
Biotech

Candel burns bright as phase 3 cancer win sends stock up 200%

Candel reported a 14.5% relative improvement in disease-free survival, an endpoint that looked at cancer recurrence or death from any cause.
Nick Paul Taylor Dec 11, 2024 9:49am
heart cardiovascular check up stethescope

NewAmsterdam shares sign drug improves cardiovascular outcomes

Dec 10, 2024 8:48am
Hybrid FSPFSO Solutions Keep Biotech Trials on Time and on Budget

Hybrid FSP/FSO Solutions Keep Biotech Trials on Time and on Budget

Nov 1, 2024 8:00am
Sketch of lungs

Roivant’s midstage asset fails to show benefit in lung disease

Dec 3, 2024 10:32am
Market Insights Whats Driving the Shift Toward FSP Models in Clinical Development

Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development?

Oct 2, 2024 8:00am
share price stock stock price shares falling falling

Pyxis' shares fall on lukewarm early ADC results in solid tumors

Nov 21, 2024 2:30pm